Cardiolipin synthesis is required to support human cholesterol biosynthesis from palmitate upon serum removal in Hela...

Area of Science:

• Biochemistry
• Cell Biology
• Metabolic Pathways

Background:

• Cholesterol (CH) is a vital lipid, and its biosynthesis is tightly regulated.
• Cardiolipin (CL) is a unique phospholipid primarily found in mitochondria, involved in various cellular processes.
• The relationship between CL synthesis and CH production, especially under cellular stress, remains incompletely understood.

Purpose of the Study:

• To investigate the role of cardiolipin (CL) synthesis in supporting cholesterol (CH) production from palmitate in Hela cells.
• To determine if inhibiting cardiolipin synthase-1 (hCLS1) impacts de novo CH biosynthesis.

Main Methods:

• Utilized Hela cells with stable knockdown of human cardiolipin synthase-1 (hCLS1) via shRNA.
• Incubated cells with [14C(U)]palmitate in the presence or absence of serum.
• Measured [14C(U)]palmitate incorporation into lipids, assessed CH pool size, and analyzed HMG-CoA reductase activity and mRNA expression.

Main Results:

• Knockdown of hCLS1 significantly reduced [14C(U)]palmitate incorporation into both CL and CH.
• This reduction in CH synthesis was most pronounced under serum-free conditions.
• No alterations in overall palmitate uptake or metabolism were observed, and CH pool size remained unaffected.
• Hydroxymethylglutaryl coenzyme A reductase activity and mRNA expression were decreased upon hCLS1 knockdown.

Conclusions:

• Cardiolipin synthesis is required to support de novo cholesterol biosynthesis in Hela cells, especially when cellular demand for CH is high (e.g., under serum-free conditions).
• hCLS1 plays a critical role in facilitating cholesterol production, likely through its impact on HMG-CoA reductase activity.